Renaissance Technologies - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 139 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$26,208
-4.4%
1,172,598
-8.0%
0.04%
+15.4%
Q2 2023$27,400
-5.5%
1,274,998
+5.5%
0.04%
+2.6%
Q1 2023$28,992
+8.3%
1,208,498
+4.7%
0.04%
+2.7%
Q4 2022$26,780
-99.9%
1,154,319
-7.0%
0.04%
+32.1%
Q3 2022$19,878,000
-19.7%
1,240,818
-11.2%
0.03%
-3.4%
Q2 2022$24,752,000
-4.3%
1,396,818
+10.0%
0.03%
-3.3%
Q1 2022$25,860,000
+10.2%
1,270,118
+1.1%
0.03%
+3.4%
Q4 2021$23,468,000
-8.9%
1,256,318
-3.7%
0.03%
-12.1%
Q3 2021$25,761,000
-12.8%
1,304,997
+4.4%
0.03%
-10.8%
Q2 2021$29,539,000
-1.5%
1,249,518
-1.3%
0.04%0.0%
Q1 2021$29,998,000
+8.3%
1,265,718
-8.5%
0.04%
+23.3%
Q4 2020$27,696,000
-7.0%
1,382,718
-3.3%
0.03%0.0%
Q3 2020$29,781,000
+4.6%
1,430,418
-12.1%
0.03%
+20.0%
Q2 2020$28,478,000
+9.9%
1,627,318
+2.6%
0.02%0.0%
Q1 2020$25,909,000
+0.5%
1,586,618
+26.7%
0.02%
+25.0%
Q4 2019$25,773,000
+200.5%
1,252,328
+67.6%
0.02%
+185.7%
Q3 2019$8,578,000
+167.2%
747,200
+206.1%
0.01%
+133.3%
Q2 2019$3,210,000
+830.4%
244,100
+1708.1%
0.00%
Q2 2018$345,0000.0%13,5000.0%0.00%
Q1 2018$345,000
-85.7%
13,500
-89.7%
0.00%
-100.0%
Q4 2017$2,415,000
+636.3%
130,800
+996.1%
0.00%
+200.0%
Q4 2015$328,000
-53.3%
11,933
-62.5%
0.00%
-50.0%
Q3 2015$703,00031,8000.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders